Literature DB >> 9100629

Restoration of immunity to chronic hepatitis B infection in HIV-infected patient on protease inhibitor.

A Carr, D A Cooper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9100629     DOI： 10.1016/S0140-6736(05)62892-9

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  18 in total

Review 1.  Management of the immune reconstitution inflammatory syndrome.

Authors:  Graeme Meintjes; James Scriven; Suzaan Marais
Journal:  Curr HIV/AIDS Rep       Date:  2012-09       Impact factor: 5.071

2.  A case for treating high hepatitis B DNA levels before starting HIV therapy.

Authors:  Jason V Baker; David R Boulware; Paul R Bohjanen
Journal:  AIDS       Date:  2006-11-28       Impact factor: 4.177

3.  Update on Hepatitis B and C Coinfection in HIV.

Authors:  Patrick Yachimski; Raymond T Chung
Journal:  Curr Infect Dis Rep       Date:  2005-07       Impact factor: 3.725

4.  Progressive neuropsychiatric problems following institution of highly active antiretroviral therapy.

Authors:  R F Miller; S S Dave; J W Tang; P J Shaw; H R Jäger; E G L Wilkins
Journal:  Sex Transm Infect       Date:  2005-08       Impact factor: 3.519

5.  Effects of protease inhibitors on the course of CMV retinitis in relation to CD4+ lymphocyte responses in HIV+ patients.

Authors:  G J van den Horn; C Meenken; S A Danner; P Reiss; M D de Smet
Journal:  Br J Ophthalmol       Date:  1998-09       Impact factor: 4.638

6.  Current management and recommendations on hepatitis B therapy in HIV-coinfected patients.

Authors:  Lionel Piroth; Sophie Mahy; Stanislas Pol; Fabrice Carrat; Damien Sene; Manuel Etienne; Caroline Lascoux-Combe; Anne Simon; Jean-Luc Schmit; Patrice Cacoub
Journal:  Hepatol Int       Date:  2011-07-15       Impact factor: 6.047

Review 7.  Management of hepatitis B in patients coinfected with the human immunodeficiency virus.

Authors:  R Lessells; C Leen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-04-27       Impact factor: 3.267

8.  An inhibitor of HIV-1 protease modulates proteasome activity, antigen presentation, and T cell responses.

Authors:  P André; M Groettrup; P Klenerman; R de Giuli; B L Booth; V Cerundolo; M Bonneville; F Jotereau; R M Zinkernagel; V Lotteau
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-27       Impact factor: 11.205

Review 9.  [Immune reconstitution inflammatory syndrome (IRIS)].

Authors:  A D Wagner
Journal:  Z Rheumatol       Date:  2008-07       Impact factor: 1.372

10.  The effect of human immunodeficiency virus on hepatitis B virus serologic status in co-infected adults.

Authors:  Michael L Landrum; Ann M Fieberg; Helen M Chun; Nancy F Crum-Cianflone; Vincent C Marconi; Amy C Weintrob; Anuradha Ganesan; Robert V Barthel; Glenn Wortmann; Brian K Agan
Journal:  PLoS One       Date:  2010-01-13       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.